Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells

European Journal of Immunology

Volumn 35, Issue 6, 2005, Pages 1692-1701

  Sriram, Venkataraman ^a,b   Du, Wenjun ^c   Gervay Hague, Jacquelyn ^c   Brutkiewicz, Randy R ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigen presentation; Glycosphingolipids; NKT cell activation

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; BACTERIUM LIPOPOLYSACCHARIDE; CARBOHYDRATE; CD1D ANTIGEN; GLYCOLIPID; GLYCOSPHINGOLIPID; LIGAND;

ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; BINDING AFFINITY; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; IMMUNOREACTIVITY; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPHINGOMONAS PAUCIMOBILIS;

EID: 20844463676     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200526157     Document Type: Article

References (48)

1. Brutkiewicz, R. R., Lin, Y., Cho, S., Hwang, Y. K., Sriram, V. and Roberts, T. J., CD1d-mediated antigen presentation to natural killer T (NKT) cells. Crit. Rev. Immunol. 2003. 23: 403-419. DOI 10.1615/CritRevImmunol.-v23.i56.
2. Porcelli, S. A. and Modlin, R. L., The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 1999. 17: 297-329. DOI 10.1146/annurev.immunol.17.1.297.
3. Zeng, Z., Castano, A. R., Segelke, B. W., Stura, E. A., Peterson, P. A. and Wilson, I. A., Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 1997. 277: 339-345. DOI 10.1126/science. 277.5324.339.
4. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E. et al., CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629. DOI 10.1126/science.278.5343.1626.
5. Skold, M. and Behar, S. M., Role of CD1d-restricted NKT cells in microbial immunity. Infect. Immun. 2003. 71: 5447-5455. DOI 10.1128/IAI.71.10.5447-5455.2003.
6. Fischer, K., Scotet, E., Niemeyer, M., Koebernick, H., Zerrahn, J., Maillet, S., Hurwitz, R., Kursar, M., Bonneville, M., Kaufmann, S. H. and Schaible, U. E., Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. U. S. A. 2004. 101: 10685-10690. DOI 10.1073/pnas.0403787101.
7. Wallner, F. K., Chen, L., Moliner, A., Jondal, M. and Elofsson, M., Loading of the antigen-presenting protein CD1d with synthetic glycolipids. Chembiochem. 2004. 5: 437-444. DOI 10.1002/cbic.200300655.
8. Natori, T., Morita, M., Akimoto, K. and Koezuka, Y., Agelasphins, novel antitumor and immunostimulatory cerebrosides from the marine sponge Agelas mauritianus. Tetrahedron 1994. 50: 2771-2784. DOI 10.1016/S00404020(01)86991-X.
9. Kawahara, K., Kuraishi, H. and Zahringer, U., Chemical structure and function of glycosphingolipids of Sphingomonas spp and their distribution among members of the α-4 subclass of Proteobacteria. J. Ind. Microbiol. Biotechnol. 1999. 23: 408-413. DOI 10.1038/sj.jim.2900708.
10. Kawahara, K., Seydel, U., Matsuura, M., Danbara, H., Rietschel, E. T. and Zahringer, U., Chemical structure of glycosphingolipids isolated from Sphingomonas paucimobilis. FEBS Lett. 1991. 292: 107-110. DOI 10.1016/0014-5793(91)80845-T.
11. Krziwon, C., Zahringer, U., Kawahara, K., Weidemann, B., Kusumoto, S., Rietschel, E. T., Flad, H. D. and Ulmer, A. J., Glycosphingolipids from Sphingomonas paucimobilis induce monokine production in human mononuclear cells. Infect. Immun. 1995. 63: 2899-2905.
12. Miyazaki, Y., Oka, S., Yamaguchi, S., Mizuno, S. and Yano, I., Stimulation of phagocytosis and phagosome-lysosome fusion by glycosphingolipids from Sphingomonas paucimobilis. J. Biochem. (Tokyo) 1995. 118: 271-277.
13. Munstermann, M., Wiese, A., Brandenburg, K., Zahringer, U., Brade, L., Kawahara, K. and Seydel, U., Complement activation by bacterial surface glycolipids: a study with planar bilayer membranes. J. Membr. Biol. 1999. 167: 223-232. DOI 10.1007 /s002329900486.
14. + NK T lymphocytes. J. Immunol. 1998. 161: 3271-3281.
15. - T cells. J. Exp. Med 1997. 186: 109-120. DOI 10.1084/jem.186.1.109.
16. Prigozy, T. I., Naidenko, O., Qasba, P., Elewaut, D., Brossay, L., Khurana, A., Natori, T., Koezuka, Y., Kulkarni, A. and Kronenberg, M., Glycolipid antigen processing for presentation by CD1d molecules. Science 2001. 291: 664-667 DOI 10.1126/science.291.5504.664.
17. Roberts, T. J., Sriram, V., Spence, P. M., Gui, M., Hayakawa, K., Bacik, I., Bennink, J. R., Yewdell, J. W. and Brutkiewicz, R. R., Recycling CD1d1 molecules present endogenous antigens processed in an endocytic compartment to NKT cells. J. Immunol. 2002. 168: 5409-5414.
18. de Duve, C., de Barsy, T., Poole, B., Trouet, A., Tulkens, P. and Van Hoof, F., Commentary. Lysosomotropic agents. Biochem. Pharmacol. 1974. 23: 2495-2531. DOI 10.1016/0006-2952(74)90174-9.
19. Wibo, M. and Poole, B., Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1. J. Cell Biol. 1974. 63: 430-440. DOI 10.1083/jcb.63.2.430.
20. Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M. and Tashiro, Y., Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 1991. 266: 17707-17712.
21. Kawasaki, S., Moriguchi, R., Sekiya, K., Nakai, T., Ono, E., Kume, K. and Kawahara, K., The cell envelope structure of the lipopolysaccharide-lacking gram-negative bacterium Sphingomonas paucimobilis. J. Bacteriol. 1994. 176: 284-290.
22. Folch, J., Lees, M. and Sloane Stanley, G. H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957. 226: 497-509.
23. Suzuki, K., The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, postmortem changes and the effect of formalin preservation. J. Neurochem. 1965. 12: 629-638.
24. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. and Brenner, M. B., Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 2003. 4: 1230-1237. DOI 10.1038/ni1002.
25. Wu, D., Xing, G. W., Poles, M. A., Horowitz, A., Kinjo, Y., Sullivan, B., Bodmer-Narkevitch, V., Plettenburg, O., Kronenberg, M., Tsuji, M. et al., Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc. Natl. Acad. Sci. U. S. A. 2005. 102: 1351-1356. DOI 10.1073/pnas.0408696102.
26. Brossay, L., Naidenko, O., Burdin, N., Matsuda, J., Sakai, T. and Kronenberg, M., Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J. Immunol. 1998. 161: 5124-5128.
27. Gui, M., Li, J., Wen, L. J., Hardy, R. R. and Hayakawa, K., TCR β chain influences but does not solely control autoreactivity of Vα14J281T cells. J. Immunol. 2001. 167: 6239-6246.
28. Bendelac, A., Rivera, M. N., Park, S. H. and Roark, J. H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 1997. 15: 535-562. DOI 10.1146/annurev.immunol.15.1.535.
29. + cells in the liver of mice. J. Exp. Med. 1994. 180: 699-704. DOI 10.1084/jem.180.2.699.
30. Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C. R., Koezuka, Y. and Kronenberg, M., Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000. 192: 741-754. DOI 10.1084/jem.192.5.741.
31. Schumann, J., Voyle, R. B., Wei, B. Y. and MacDonald, H. R., Cutting edge: influence of the TCR Vβ domain on the avidity of CD1d: α-galactosylceramide binding by invariant Vα14 NKT cells. J. Immunol. 2003. 170: 5815-5819.
32. Matsuda, J. L., Gapin, L., Fazilleau, N., Warren, K., Naidenko, O. V. and Kronenberg, M., Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size. Proc. Natl. Acad. Sci. U. S. A. 2001. 98: 12636-12641. DOI 10.1073/pnas.221445298.
33. Sidobre, S., Naidenko, O. V., Sim, B. C., Gascoigne, N. R., Garcia, K. C. and Kronenberg, M., The Vα14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J. Immunol. 2002. 169: 1340-1348.
34. Kronenberg, M. and Gapin, L., The unconventional lifestyle of NKT Cells. Nat. Rev. Immunol. 2002. 2: 557-568.
35. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. and Wakao, H., The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 2003. 21: 483-513. DOI 10.1146/annurev.immunol.21.120601.141057.
36. Makowska, A., Kawano, T., Taniguchi, M. and Cardell, S., Differences in the ligand specificity between CD1d-restricted T cells with limited and diverse T-cell receptor repertoire. Scand. J. Immunol. 2000. 52: 71-79. DOI 10.1046 /j.1365-3083.2000.00754.x.
37. Burdin, N., Brossay, L., Degano, M., Iijima, H., Gui, M., Wilson, I. A. and Kronenberg, M., Structural requirements for antigen presentation by mouse CD1. Proc. Natl. Acad. Sci. U. S. A. 2000. 97: 10156-10161. DOI 10.1073/pnas.97.18.10156.
38. Yu, K. O., Im, J. S., Molano, A., Dutronc, Y., Illarionov, P. A., Forestier, C., Fujiwara, N., Arias, I., Miyake, S., Yamamura, T. et al., Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc. Natl. Acad. Sci. U. S. A. 2005. 102: 3383-3388. DOI 10.1073 /pnas.0407488102.
39. Zhou, X. T., Forestier, C., Goff, R. D., Li, C., Teyton, L., Bendelac, A. and Savage, P. B., Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6″-amino-6″-deoxy-galactosylceramides. Org. Lett. 2002. 4: 1267-1270. DOI 10.1021/ol025565+.
40. Hsueh, P. R., Teng, L. J., Yang, P. C., Chen, Y. C., Pan, H. J., Ho, S. W. and Luh, K. T., Nosocomial infections caused by Sphingomonas paucimobilis: clinical features and microbiological characteristics. Clin. Infect. Dis. 1998. 26: 676-681.
41. Perola, O., Nousiainen, T., Suomalainen, S., Aukee, S., Karkkainen, U. M., Kauppinen, J., Ojanen, T. and Katila, M. L., Recurrent Sphingomonas paucimobilis-bacteraemia associated with a multi-bacterial water-borne epidemic among neutropenic patients. J. Hosp. Infect. 2002. 50: 196-201. DOI 10.1053/jhin.2001.1163. DOI 10.1038/nature03407.
42. Kinjo, Y., Wu, D., Kim, G., Xing, G. W., Poles, M. A., Ho, D. D., Tsuji, M., Kawahara, K., Wong, C. H. and Kronenberg, M., Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005. 434: 520-525.
43. Mattner, J., Debord, K. L., Ismail, N., Goff, R. D., Cantu, C. III, Zhou, D., Saint-Mezard, P., Wang, V., Gao, Y., Yin, N. et al., Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005. 434: 525-529. DOI 10.1038/nature03408.
44. + T cell lymphoma by natural killer T (NKT) cells. Proc. Natl. Acad. Sci. U. S. A. 2002. 99: 8197-8202. DOI 10.1073/pnas.122636199.
45. - T cells in mice and humans. J. Exp. Med. 1994. 180: 1097-1106. DOI 10.1084/jem.180.3.1097.
46. Williams, M. A. and McCluer, R. H., The use of Sep-Pak C18 cartridges during the isolation of gangliosides. J. Neurochem. 1980. 35: 266-269.
47. Svennerholm, L., The quantitative estimation of cerebrosides in nervous tissue. J. Neurochem. 1956. 1: 42-53.
48. Hobbs, J. A., Cho, S., Roberts, T. J., Sriram, V., Zhang, J., Xu, M. and Brutkiewicz, R. R., Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus. J. Virol 2001. 75: 10746-10754. DOI 10.1128/JVI.75.22.10746-10754.2001.